Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Locations section now lists Michigan and New York under a single Locations heading, replacing the prior separate location blocks.SummaryDifference0.4%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded a PubMed auto-fill note clarifying that publications shown may be automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the government funding status banner that warned about updates and operating status. The banner previously appeared on the study page.SummaryDifference0.4%

- Check66 days agoChange DetectedBoth screenshots show no additions or deletions on the study details page; the layout and core sections remain unchanged.SummaryDifference0.4%

- Check95 days agoChange DetectedMajor update to page status and version: add operating-status notices and new version v3.2.0; remove a specific disease resource (Adrenal cortex carcinoma) and old version v3.1.0.SummaryDifference4%

- Check102 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.